Cite
HARVARD Citation
Kourie, H. et al. (n.d.). Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations. Expert opinion on drug metabolism and toxicology. pp. 947-957. [Online].